Langerhan's cell histiocytosis after living donor liver transplantation: Report of a case

Liver Transplantation

Volumn 11, Issue 11, 2005, Pages 1435-1438

  Honda, Ryoko ^a   Ohno, Yasuharu ^a   Iwasaki, Takuya ^b   Okudaira, Sadayuki ^a   Okada, Masahiko ^a   Kamitamari, Akira ^a   Ohshima, Koichi ^c   Moriuchi, Hiroyuki ^a   Kanematsu, Takashi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CD3 ANTIBODY; CYCLOPHOSPHAMIDE; DOXORUBICIN; GANCICLOVIR; METHYLPREDNISOLONE; PREDNISONE; STEROID; TACROLIMUS; VINCRISTINE; VIRUS DNA; ANTINEOPLASTIC AGENT;

ACUTE GRAFT REJECTION; ARTICLE; CASE REPORT; CYTOMEGALOVIRUS INFECTION; DEATH; EPSTEIN BARR VIRUS; FEMALE; HEPATITIS; HISTIOCYTOSIS X; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONOR; LYMPH NODE BIOPSY; LYMPHADENOPATHY; PANCYTOPENIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RASH; REMISSION; SKIN BIOPSY; VIRUS REACTIVATION; FOLLOW UP; HOSPITALIZATION; IMMUNOHISTOCHEMISTRY; METHODOLOGY; NEEDLE BIOPSY; PATHOLOGY; POSTOPERATIVE COMPLICATION; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; FEMALE; FOLLOW-UP STUDIES; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; LIVING DONORS; POSTOPERATIVE COMPLICATIONS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 30444437604     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20589     Document Type: Article

References (17)

1. Kauffman HM, Cherikh WS, Cheng Y. Posttransplantation malignancies: a problem, a challenge, and an opportunity. Liver Transpl 2002;8:488-490.
2. Sanchez EQ, Marubashi S, Jung G, Levy MF, Goldstein RM, Molmenti EP, et al. De novo tumors after liver transplantation: a single-institution experience. Liver Transpl 2002;8:285-291.
3. Preiksaitis JK, Keay S. Diagnosis and management of posttranplant lymphoproliferative disorder in solid-organ transplant recipients. Clin Infect Dis 2001;33:S38-S46.
4. Jain A, Nalesnik M, Reyes J, Pokharna R, Mazariegos G, Green M, et al. Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg 2002;236:429-437.
5. Willman CL, Busque L, Griffith BB, Favara BE, McClain KL, Duncan MH, Gilliland DG. Langerhans'-cell histiocytosis (histiocytosis X): a clonal proliferative disease. N Engl J Med 1994; 331:154-160.
6. Yu RC, Chu C, Buluwela L, Chu AC. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet 1994; 343:767-768.
7. Chu T, Jaffe R. The normal Langerhans cell and the LCH cell. Br J Cancer 1994;23(Suppl):S4-S10.
8. Howarth DM, Gilchrist GS, Mullan BP, Wiseman GA, Edmonson JH, Schomberg PJ. Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer 1999;85: 2278-2290.
9. Melendez HV, Dhawan A, Mieli-Vergani G, Rela M, Heaton ND, Pritchard J, Mowat A. Liver transplantation for Langerhans' cell histiocytosis: a case report and literature review. Transplantation 1996;62:1167-1171.
10. Kinugawa N, Imashuku S, Hirota Y, Yamada K, Yamamoto A, Akazai A, et al. Hematopoietic stem cell transplantation (HSCT) for Langerhans cell histiocytosis (LCH) in Japan. Bone Marrow Transplant 1999;24:935-938.
11. Hadzic N, Pritchard J, Webb D, Portmann B, Heaton ND, Rela M, et al. Recurrence of Langerhans cell histiocytosis in the graft after pediatric liver transplantation. Transplantation 2000;70: 815-819.
12. Hengge UR, Ruzicka T, Tyring SK, Stuschke M, Roggendorf M, Schwartz RA, Seeber S. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma. Lancet Infect Dis 2002;2:344-352.
13. Shimakage M, Sasagawa T, Kimura M, Shimakage T, Seto S, Kodama K, Sakamoto H. Expression of Epstein-Barr virus in Langerhans' cell histiocytosis. Hum Pathol 2004;35:862-868.
14. Chen CJ, Ho TY, Lu JJ, Sheu LF, Lee SY, Tien CH, Cheng SN. Identical twin brothers concordant for Langerhans' cell histiocytosis and discordant for Epstein-Barr virus-associated haemophagocytic syndrome. Eur J Pediatr 2004;163:536-539.
15. Corbeel L. Langerhans histiocytosis, haemophagocytic syndrome and Epstein-Barr virus infection. Eur J Pediatr 2004;163: 570-571.
16. Egeler RM, Favara BE, van Meurs M, Laman JD, Claassen E. Differential in situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood 1999;94: 4195-4201.
17. Egeler RM, Favara BE, Laman JD, Claassen E. Abundant expression of CD40 and CD40-ligand (CD154) in paediatric Langerhans cell histiocytosis lesions. Eur J Cancer 2000;36:2105-2110.